Pharmaceuticals
Our pharmaceutical practice encompasses all IP issues relating to drug products, from early-stage development through commercialization. We have extensive experience with Hatch-Waxman litigation, ANDA challenges, Orange Book strategies, and related FDA regulatory issues.
Key Capabilities
- Hatch-Waxman Act Litigation
- NDA/ANDA Patent Strategy
- Orange Book Issues
- Drug Patent Portfolio Management